Clinical Diagnostics Technology & Disease Research News | 360Dx
Emerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.
About Us - 360Dx
GenomeWeb Crain Communications, Inc. 685 Third Avenue New York, NY 10017 T: 212-210-0100
360Dx Top 30 Falls 4 Percent in December
5 days ago · Editor’s Note: We will adjust the firms listed in the 360Dx Top 30 this month based on market caps at the end of 2024. Those changes will be reflected next month when we report on the stock performance in January of the companies we track. NEW YORK – The 360Dx Top 30 fell 4 percent month over ...
Top Five Articles on 360Dx Last Week: Sepsis Testing in 2024; …
1 day ago · NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) Sepsis Test Developers Progress on Commercialization, Market Approvals of Rapid Tests During 2024 2) FDA Rule on LDTs Dominates Clinical Lab Landscape in 2024 3) Foresight Diagnostics, Stanford, Others File Motions to Dismiss Roche Suit
360Dx Top 30 Rebounds in 2024, Rises 4 Percent | 360Dx
4 days ago · Editor’s Note: We will adjust the firms listed in the 360Dx Top 30 this month based on market caps at the end of 2024. Those changes will be reflected next month when we report on the stock performance in January of the companies we track.
Frequently Asked Questions - 360Dx
What is 360Dx? 360Dx, launched in 2016, covers emerging economic and technological trends in the clinical diagnostic market. Our dedicated online newsroom tracks the biggest players in the diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.
360Dx Top 30 Slides 1 Percent in January
Jan 31, 2024 · Note: The 360Dx Top 30 has been updated with new entries Biodesix, MDxHealth, OraSure Technologies, and Sera Prognostics based on market cap as of beginning of trading in January 2024.
360Dx Top 30 Rises 3 Percent in May
Jun 4, 2024 · NEW YORK – Rebounding from a 6 percent tumble in April, the 360Dx Top 30 rose nearly 3 percent in May. The Top 30 reflected broader market trends as the Dow Jones Industrial Average rose 2 percent and the Nasdaq grew 7 percent last month, while the Nasdaq Biotech Index increased 6 percent month over month.
Mixed Month for Diagnostics Stocks as 360Dx Top 30 Ticks up 1 …
Dec 2, 2024 · NEW YORK – After a 3 percent decline in October, the 360Dx Top 30 has reversed course, rising 1 percent in November. The Top 30 trailed the performance of the Dow Jones Industrial Average, which rose nearly 8 percent, and the Nasdaq, which was up 6 percent. The Nasdaq Biotech Index, meanwhile, was ...
Diagnostics Business & Financial News - 360Dx
Dec 30, 2024 · The government alleges Labcorp and UHS delayed submission of orders for tests by Caris Life Sciences to enable improper billings to Medicare for those tests. The German IVD developer said that it plans to offer 1.6 million shares on the Nasdaq Global Market. With the approval, Bionano's OEM partner ...